Dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults with HIV with and without genotypic resistance testing results. 96-Week effectiveness and tolerability of REDOLA study.
Alfonso Cabello-Ubeda, Juan Carlos López Bernardo de Quirós, Álvaro Mena, Miguel Torralba, Luz Martín Carbonero, Ángela Gutiérrez, Jorge Vergas, Adriana Pinto, Francisco Tejerina, Esmeralda Palmier, Jesús Sanz, Miguel Górgolas, Federico Pulido
{"title":"Dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naïve adults with HIV with and without genotypic resistance testing results. 96-Week effectiveness and tolerability of REDOLA study.","authors":"Alfonso Cabello-Ubeda, Juan Carlos López Bernardo de Quirós, Álvaro Mena, Miguel Torralba, Luz Martín Carbonero, Ángela Gutiérrez, Jorge Vergas, Adriana Pinto, Francisco Tejerina, Esmeralda Palmier, Jesús Sanz, Miguel Górgolas, Federico Pulido","doi":"10.1097/QAI.0000000000003721","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":520658,"journal":{"name":"Journal of acquired immune deficiency syndromes (1999)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of acquired immune deficiency syndromes (1999)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003721","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
